Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Can tigecycline treat viral or fungal infections?

See the DrugPatentWatch profile for tigecycline

Can tigecycline treat viral infections?

Tigecycline is an antibiotic. It stops bacteria from making proteins they need to survive. It works only against bacterial infections.

Can tigecycline treat fungal infections?

Tigecycline does not work against fungi. It has no activity against yeast or molds. Doctors do not use it for fungal infections.

What organisms does tigecycline cover?

Tigecycline covers many gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It also covers many gram-negative bacteria such as Klebsiella pneumoniae and Enterobacter species. It shows activity against anaerobes and against atypical bacteria.

What happens if someone takes tigecycline for a viral or fungal infection?

The infection keeps progressing because tigecycline has no effect on viruses or fungi. Patients may experience side effects such as nausea, vomiting, or increased liver enzymes without gaining any benefit.

How long does the FDA label allow tigecycline use?

The FDA approves tigecycline for complicated skin infections, intra-abdominal infections, and community-acquired bacterial pneumonia. It does not approve it for viral or fungal conditions. The label warns against using it for blood infections.

When does tigecycline's patent expire?

Tigecycline's patent expired in 2015. Generic versions have been available since 2016. [1]

Tigecycline's main competitor products

Generic tigecycline is now available from multiple manufacturers. The original brand name drug, Tygacil, was developed by Wyeth.



Other Questions About Tigecycline :

How effective is tigecycline against certain bacteria? How frequently does tigecycline succeed in mixed therapies? Does tigecycline overuse lower survival odds in severe infections? How does tigecycline resistance vary by region in anaerobes? Are there any potential drawbacks to using tigecycline? What impact do antacids have on tigecycline's antibacterial action? How should tigecycline's volume of distribution influence treatment planning?